ETFs positioned on Vertex Pharmaceuticals Incorporated

Name YTD change Weight AuM
+10.18% - 44,934 M€
+15.41% - 35,761 M€
+8.50% - 27,154 M€
+15.28% - 750 M€
+14.64% - 507 M€
+0.18% - 293 M€
+2.35% - 165 M€
+14.41% - 148 M€
+11.49% - 122 M€
+3.44% - 80 M€
+9.28% - 75 M€
0.00% - 67 M€
+13.17% - 66 M€
-7.70% - 49 M€
+3.61% - 37 M€
+13.36% - 33 M€
+11.28% - 33 M€
+8.43% - 28 M€
+30.03%9.51% 15 M€
+35.91%9.43% 429 M€
+28.56%9.05% 1,079 M€
+28.43%9.05% 78 M€
+28.68%8.88% 9,953 M€
+28.40%8.54% 81 M€
+17.70%4.47% 7 M€
+19.63%4.4% 28 M€
+33.88%4.33% 11 M€
+49.19%4.15% 58 M€
+48.14%4.13% 87 M€
Logo Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated specializes in the research, development and marketing of micromolecular drugs primarily for the treatment of cancers, viral, inflammatory and auto-immune diseases. Net sales are distributed geographically as follows: the United States (62.9%), Europe (28.8%) and other (8.3%).
Employees
6,400
  1. Stock Market
  2. Stocks
  3. VRTX Stock
  4. ETFs Vertex Pharmaceuticals Incorporated